Chelsea Therapeutics (CHTP) Reports Q4 Loss of 20c/Share

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) reported Q4 EPS of ($0.20), $0.12 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Chelsea Therapeutics International Ltd. (CHTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance